Searchable abstracts of presentations at key conferences in endocrinology

ea0038p424 | Steroids | SFEBES2015

X-linked adrenoleukodystrophy – how to improve identification in the Addison’s population

Tapper Louis , Hogg Sarah , Wood Graham , Harrison Karen , Parker Alasdair

Objective: X-linked adrenoleukodystrophy (X-ALD) is a rare, sometimes devastating disorder caused by-mainly inherited- mutations in the ABCD1 gene. Cerebral X-ALD can be prevented or modified if diagnosed presymptomatically. Mutation can lead to very long chain fatty acid (VLCFA) accumulation in adrenocortical cells, which can cause antibody negative primary Addison’s disease (ANPAD). There are recommendations that all males affected by ANPAD should have VLCFA analysis. W...

ea0028p93 | Clinical practice/governance and case reports | SFEBES2012

Intractable nephrogenic diabetes insipidus, transient thyroiditis and hypercalcaemia complicating long term Lithium therapy

Kamath Chandan , Govindan Jyotish , Premawardhana Amila , Wood Sarah , Adlan Mohamed , Premawardhana Lakdasa

Introduction Lithium (Li) is an effective treatment for bipolar and schizo-affective disorders. It has a narrow therapeutic index, and produces common side effects when this is exceeded. Li causes endocrine disruption by predictable and some hitherto unclear mechanisms. We present a subject who developed multiple Li induced endocrinopathies concurrently, and was a therapeutic challenge. Case presentation and investigations Mr. DM had been on Li for 10 years and developed polyu...